| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17,8 M € | +9.5% | 16,3 M € | +3.4% | 15,7 M € | -0.9% | 15,9 M € | -52.9% | 33,7 M € | -53.3% | 72,2 M € | +13.8% | 63,5 M € | +24.8% | 50,9 M € | +26.0% | 40,4 M € | +10.7% | 36,4 M € | +7.0% | 34,1 M € | +1.8% | 33,5 M € | +0.3% | 33,4 M € | +1.5% | 32,9 M € | +2.8% | 32,0 M € | +6.2% | 30,1 M € | +6.4% | 28,3 M € | +8.7% | 26,0 M € | +18.7% | 21,9 M € | +14.0% | 19,2 M € | |
| EBITDA | 1,2 M € | +33.1% | 918,6 k € | -11.7% | 1,0 M € | +11.4% | 933,9 k € | -77.0% | 4,1 M € | +165.9% | 1,5 M € | +310.5% | -726,4 k € | -203.4% | 702,7 k € | +87.3% | 375,1 k € | +16.2% | 322,8 k € | +115.6% | 149,7 k € | -72.8% | 550,6 k € | +607.7% | -108,5 k € | -140.3% | 269,0 k € | -52.1% | 561,5 k € | +30.3% | 431,0 k € | -6.1% | 459,2 k € | +195.5% | 155,4 k € | +52.4% | 102,0 k € | -60.1% | 255,8 k € | |
| Operating profit | 589,9 k € | +5.6% | 558,9 k € | -4.2% | 583,4 k € | +9.3% | 533,9 k € | -85.2% | 3,6 M € | +230.3% | 1,1 M € | +198.8% | -1,1 M € | -320.4% | 501,8 k € | +201.9% | 166,2 k € | -20.5% | 209,2 k € | +119.2% | 95,4 k € | -43.5% | 169,0 k € | +143.5% | -388,7 k € | -304.8% | 189,8 k € | -51.5% | 391,0 k € | +30.7% | 299,2 k € | -16.4% | 358,1 k € | +16924.1% | -2,1 k € | +91.6% | -25,4 k € | -119.0% | 133,9 k € | |
| Profit/loss | 358,2 k € | +15.4% | 310,4 k € | +3.6% | 299,8 k € | +12.5% | 266,3 k € | -92.2% | 3,4 M € | +251.1% | 968,8 k € | +182.5% | -1,2 M € | -518.3% | 280,6 k € | +543.2% | 43,6 k € | -50.0% | 87,2 k € | +22.5% | 71,2 k € | -44.2% | 127,6 k € | +127.2% | -469,8 k € | -476.3% | 124,8 k € | -50.7% | 253,0 k € | -13.1% | 291,2 k € | +21.5% | 239,7 k € | +441.4% | -70,2 k € | -377.5% | 25,3 k € | -77.4% | 112,1 k € | |
| Equity | 4,7 M € | +8.3% | 4,3 M € | +7.8% | 4,0 M € | -54.1% | 8,7 M € | +3.2% | 8,4 M € | +67.6% | 5,0 M € | +23.9% | 4,1 M € | -22.4% | 5,2 M € | +5.7% | 5,0 M € | +0.9% | 4,9 M € | +1.8% | 4,8 M € | +1.5% | 4,8 M € | +2.8% | 4,6 M € | -9.2% | 5,1 M € | +2.5% | 5,0 M € | +5.4% | 4,7 M € | +6.6% | 4,4 M € | +5.7% | 4,2 M € | -1.7% | 4,3 M € | +0.6% | 4,2 M € | |
| Total assets | 9,7 M € | +8.0% | 9,0 M € | -4.9% | 9,5 M € | -47.2% | 17,9 M € | +8.8% | 16,5 M € | -17.9% | 20,1 M € | +12.4% | 17,9 M € | +9.5% | 16,3 M € | +19.8% | 13,6 M € | +9.7% | 12,4 M € | +5.6% | 11,8 M € | -4.6% | 12,3 M € | -6.4% | 13,2 M € | -31.6% | 19,3 M € | +7.1% | 18,0 M € | -1.7% | 18,3 M € | +19.8% | 15,3 M € | -5.8% | 16,2 M € | +24.5% | 13,0 M € | +17.5% | 11,1 M € | |
| Cash | 1,5 M € | +175.5% | 557,4 k € | -66.1% | 1,6 M € | -2.1% | 1,7 M € | +176.9% | 607,2 k € | -60.9% | 1,6 M € | -37.0% | 2,5 M € | +74.9% | 1,4 M € | +16.6% | 1,2 M € | +83.6% | 657,7 k € | -63.2% | 1,8 M € | +105.9% | 869,0 k € | +11.4% | 780,4 k € | -30.7% | 1,1 M € | -2.3% | 1,2 M € | -60.2% | 2,9 M € | +9.9% | 2,6 M € | +49.3% | 1,8 M € | +199.4% | 589,9 k € | +45.5% | 405,3 k € | |
| Debts | 4,9 M € | +8.3% | 4,5 M € | -14.1% | 5,2 M € | -42.8% | 9,1 M € | +15.9% | 7,9 M € | -46.7% | 14,8 M € | +9.0% | 13,6 M € | +25.6% | 10,8 M € | +26.1% | 8,6 M € | +16.5% | 7,4 M € | +7.2% | 6,9 M € | -9.5% | 7,6 M € | -11.0% | 8,5 M € | -39.8% | 14,1 M € | +8.7% | 13,0 M € | -4.1% | 13,6 M € | +26.5% | 10,7 M € | -10.6% | 12,0 M € | +37.2% | 8,7 M € | +28.1% | 6,8 M € | |
| Staff | 27,1 | 26,7 | 24,4 | 25,7 | 27,9 | 38,9 | 37 | 39 | 36 | 36,4 | 34,5 | 35 | 39,6 | 37,5 | 36 | 35,1 | 33,2 | 29,7 | 28,5 | 29,3 | ||||||||||||||||||||
Public limited company · Wavre · incorporated on 07/10/1960 · 27,1 ETP
Public limited company profitable and well capitalised. Cash position rising (+175.5%).
Solid counterparty for a standard engagement.
Will - Pharma is a Public limited company incorporated in 1960. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Wavre. It employs on average 27,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette